Lobbying

Wex Health's latest lobbying report covers Q2 2026, at $50K. The four quarters Q3 2025–Q2 2026 total $200K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Wex Health

Latest quarter
$50K
Q2 2026 · 1 reports
Last 12 months
$200K
Last 4 quarters
vs last quarter
0.0%
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Wex Health lobbying by quarter
Wex Health lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$50K1
Q2 2023$50K1
Q3 2023$50K1
Q4 2023$50K1
Q1 2024$50K1
Q2 2024$50K1
Q3 2024$50K1
Q4 2024$50K1
Q1 2025$50K1
Q2 2025$50K1
Q3 2025$50K1
Q4 2025$50K1
Q1 2026$50K1
Q2 2026$50K1

Policy issues the reports name

  • Health issues12 reports
  • Medicare and Medicaid6 reports
  • Banking3 reports
  • Taxation1 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
The McManus Group$750K15 quarters

Former officials lobbying for it

Former position
ALANNA TEMMELD, Rep. Jon PorterQ2 2023
JOHN MCMANUSStaff Director W&M Health Subcommittee; LA, Rep. Bill ThomasQ2 2023

Lobbying reports

Filed by
07/20for Q2The McManus Group$50K
04/20for Q1The McManus Group$50K
01/20for Q4 2025The McManus Group$50K
25/10/20for Q3 2025The McManus Group$50K
25/07/21for Q2 2025The McManus Group$50K
25/04/21for Q1 2025The McManus Group$50K
25/01/21for Q4 2024The McManus Group$50K
24/10/21for Q3 2024The McManus Group$50K
24/07/16for Q2 2024The McManus Group$50K
24/04/22for Q1 2024The McManus Group$50K
24/01/20for Q4 2023The McManus Group$50K
23/10/20for Q3 2023The McManus Group$50K
23/07/20for Q2 2023The McManus Group$50K
23/04/20for Q1 2023The McManus Group$50K
23/01/20for Q4 2022The McManus Group$50K